Temat: "Dopamine -- Agonists" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Operative treatment of cystic prolactinomas: a retrospective study.
Autorzy:: Su W; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
He K; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yang Y; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Xu J; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Li X; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Tang H; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yang J; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yang L; Neurosurgery Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. .; Pokaż więcej
Źródło:: BMC endocrine disorders [BMC Endocr Disord] 2023 May 04; Vol. 23 (1), pp. 99. Date of Electronic Publication: 2023 May 04.
Typ publikacji:: Journal Article
MeSH Terms:: Prolactinoma*/drug therapy
Prolactinoma*/surgery
Pituitary Neoplasms*/surgery
Pituitary Neoplasms*/drug therapy
Humans ; Retrospective Studies ; Treatment Outcome ; Prolactin ; Dopamine Agonists/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Macroprolactinoma with secondary resistance to dopamine agonists: a case report and review of the literature.
Autorzy:: Tng EL; Department of Medicine, Ng Teng Fong General Hospital, 1 Jurong East Street 21, Tower A Level 8, Singapore, 609606, Singapore. .
Teo AE; Department of Medicine, Division of Endocrinology, National University Health System, 1E Kent Ridge Road, NUHS Tower Block Level 10, Singapore, 119228, Singapore.
Aung AT; Ministry of Health Holdings, 1 Maritime Square, #11-25 HarbourFront Centre, Singapore, 099253, Singapore.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2023 Mar 17; Vol. 17 (1), pp. 96. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:: Review; Case Reports; Journal Article
MeSH Terms:: Prolactinoma*
Pituitary Neoplasms*/pathology
Male ; Humans ; Middle Aged ; Dopamine Agonists/therapeutic use ; Cabergoline/therapeutic use ; Ergolines/therapeutic use ; Prolactin

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Rapid and dramatic glucose-lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma.
Autorzy:: Igata M; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yagi Y; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Hanatani S; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Sakaguchi M; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Ishii N; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yoshinaga K; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Kawashima J; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Motoshima H; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Araki E; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.; Pokaż więcej
Źródło:: Journal of diabetes investigation [J Diabetes Investig] 2021 Apr; Vol. 12 (4), pp. 668-671. Date of Electronic Publication: 2020 Aug 25.
Typ publikacji:: Case Reports
MeSH Terms:: Blood Glucose/*drug effects
Bromocriptine/*therapeutic use
Diabetes Mellitus, Type 2/*drug therapy
Dopamine Agonists/*therapeutic use
Prolactinoma/*drug therapy
Bromocriptine/pharmacology ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/complications ; Dopamine Agonists/pharmacology ; Female ; Humans ; Middle Aged ; Prolactinoma/complications

Raport

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: The side effects of dopamine receptor agonist drugs in Chinese prolactinoma patients: a cross sectional study.
Autorzy:: Ke X; Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Dongcheng District, Key Laboratory of Endocrinology of National Health Commission, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, PekingBeijing, 100730, China.
Wang L; Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Dongcheng District, Key Laboratory of Endocrinology of National Health Commission, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, PekingBeijing, 100730, China.
Chen M; Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Dongcheng District, Key Laboratory of Endocrinology of National Health Commission, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, PekingBeijing, 100730, China.
Liu S; Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Dongcheng District, Key Laboratory of Endocrinology of National Health Commission, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, PekingBeijing, 100730, China.
Yu N; Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Dongcheng District, Key Laboratory of Endocrinology of National Health Commission, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, PekingBeijing, 100730, China.
Duan L; Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Dongcheng District, Key Laboratory of Endocrinology of National Health Commission, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, PekingBeijing, 100730, China.
Gong F; Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Dongcheng District, Key Laboratory of Endocrinology of National Health Commission, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, PekingBeijing, 100730, China.
Zhu H; Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Dongcheng District, Key Laboratory of Endocrinology of National Health Commission, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, PekingBeijing, 100730, China. .; Pokaż więcej
Źródło:: BMC endocrine disorders [BMC Endocr Disord] 2022 Apr 11; Vol. 22 (1), pp. 97. Date of Electronic Publication: 2022 Apr 11.
Typ publikacji:: Journal Article
MeSH Terms:: Disruptive, Impulse Control, and Conduct Disorders*/chemically induced
Disruptive, Impulse Control, and Conduct Disorders*/drug therapy
Pituitary Neoplasms*/drug therapy
Pituitary Neoplasms*/epidemiology
Prolactinoma*/drug therapy
Prolactinoma*/epidemiology
China/epidemiology ; Cross-Sectional Studies ; Dopamine Agonists/adverse effects ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas.
Autorzy:: Wang S; Central lab, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, 241 Pengliuyang Road, Wuchang District, Wuhan, 430060, Hubei, China.; Department of Pharmacy, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, Wuhan, 430060, Hubei, China.; College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, Hubei, China.
Wang A; Health Examination Center, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, 241 Pengliuyang Road, Wuchang District, Wuhan, 430060, Hubei, China.
Zhang Y; Central lab, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, 241 Pengliuyang Road, Wuchang District, Wuhan, 430060, Hubei, China.; Department of Pharmacy, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, Wuhan, 430060, Hubei, China.; College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, Hubei, China.
Zhu K; Central lab, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, 241 Pengliuyang Road, Wuchang District, Wuhan, 430060, Hubei, China.; Department of Pharmacy, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, Wuhan, 430060, Hubei, China.; College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, Hubei, China.
Wang X; Central lab, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, 241 Pengliuyang Road, Wuchang District, Wuhan, 430060, Hubei, China.; Department of Pharmacy, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, Wuhan, 430060, Hubei, China.
Chen Y; Department of Pharmacy, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, Wuhan, 430060, Hubei, China.
Wu J; Central lab, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, 241 Pengliuyang Road, Wuchang District, Wuhan, 430060, Hubei, China. .; Department of Pharmacy, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, Wuhan, 430060, Hubei, China. .; Pokaż więcej
Źródło:: BMC endocrine disorders [BMC Endocr Disord] 2021 Nov 23; Vol. 21 (1), pp. 235. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji:: Journal Article
MeSH Terms:: Dopamine Agonists/*therapeutic use
Pituitary Neoplasms/*drug therapy
Pituitary Neoplasms/*enzymology
Prolactinoma/*drug therapy
Prolactinoma/*enzymology
p38 Mitogen-Activated Protein Kinases/*physiology
Animals ; Apoptosis ; Bromocriptine/therapeutic use ; Cell Line, Tumor ; Disease Models, Animal ; Drug Resistance ; Estradiol/administration & dosage ; Estradiol/analogs & derivatives ; Female ; Gene Expression Regulation/drug effects ; Mitogen-Activated Protein Kinase 11/genetics ; Mitogen-Activated Protein Kinase 12/genetics ; Mitogen-Activated Protein Kinase 13/genetics ; Mitogen-Activated Protein Kinase 14/genetics ; Prolactin/genetics ; Prolactinoma/chemically induced ; Rats ; Rats, Sprague-Dawley ; Receptors, Dopamine D1/genetics ; Signal Transduction/physiology ; p38 Mitogen-Activated Protein Kinases/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis.
Autorzy:: Zou Y; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
Li D; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
Gu J; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
Chen S; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
Wen X; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
Dong J; Jiangmen Central Hospital, Affiliated Jiangmen hospital of Sun Yat-Sen University, Jiangmen, 519000, China. .
Jiang X; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China. .; Jiangmen Central Hospital, Affiliated Jiangmen hospital of Sun Yat-Sen University, Jiangmen, 519000, China. .; Pokaż więcej
Źródło:: BMC endocrine disorders [BMC Endocr Disord] 2021 Nov 13; Vol. 21 (1), pp. 225. Date of Electronic Publication: 2021 Nov 13.
Typ publikacji:: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:: Deprescriptions*
Dopamine Agonists/*therapeutic use
Neoplasm Recurrence, Local/*epidemiology
Pituitary Neoplasms/*drug therapy
Prolactinoma/*drug therapy
Bromocriptine/therapeutic use ; Cabergoline/therapeutic use ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications.
Autorzy:: Biagetti B; Diabetes and Metabolism Research Unit, Vall d'Hebron University Hospital and Vall d'Hebron Research Institute (VHIR), Universidad Autónoma de Barcelona, 08035 Barcelona, Spain.
Simò R; Diabetes and Metabolism Research Unit, Vall d'Hebron University Hospital and Vall d'Hebron Research Institute (VHIR), Universidad Autónoma de Barcelona, 08035 Barcelona, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Oct 18; Vol. 22 (20). Date of Electronic Publication: 2021 Oct 18.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Antineoplastic Agents/*therapeutic use
Dopamine Agonists/*therapeutic use
Pituitary Neoplasms/*drug therapy
Prolactinoma/*drug therapy
Signal Transduction/*drug effects
Animals ; Humans ; Pituitary Neoplasms/metabolism ; Pituitary Neoplasms/pathology ; Prolactinoma/metabolism ; Prolactinoma/pathology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report.
Autorzy:: Koguchi M; Department of Neurosurgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
Nakahara Y; Department of Neurosurgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan. .
Ebashi R; Department of Neurosurgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
Ogata A; Department of Neurosurgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
Shimokawa S; Department of Neurosurgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
Masuoka J; Department of Neurosurgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
Abe T; Department of Neurosurgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2019 Jan 20; Vol. 13 (1), pp. 18. Date of Electronic Publication: 2019 Jan 20.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Cabergoline/*administration & dosage
Dopamine Agonists/*administration & dosage
Frontal Lobe/*pathology
Pituitary Neoplasms/*drug therapy
Prolactinoma/*drug therapy
Status Epilepticus/*chemically induced
Adult ; Anticonvulsants/therapeutic use ; Cabergoline/adverse effects ; Dopamine Agonists/adverse effects ; Fatigue ; Frontal Lobe/drug effects ; Humans ; Hydrocortisone/therapeutic use ; Magnetic Resonance Imaging ; Male ; Pituitary Neoplasms/diagnostic imaging ; Pituitary Neoplasms/physiopathology ; Prolactinoma/diagnostic imaging ; Prolactinoma/physiopathology ; Thyroxine/therapeutic use ; Treatment Outcome ; Vision Disorders

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Current Status of Surgery in Management of Prolactinomas.
Autorzy:: Panigrahi MK; Department of Neurosurgery, Krishna Institute of Medical Sciences, Secunderabad, Telangana, India.
Chandrasekhar YBVK; Department of Neurosurgery, Krishna Institute of Medical Sciences, Secunderabad, Telangana, India.
Vooturi S; Department of Neurology, Krishna Institute of Medical Sciences, Secunderabad, Telangana, India.; Pokaż więcej
Źródło:: Neurology India [Neurol India] 2020 May-Jun; Vol. 68 (Supplement), pp. S39-S43.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Neurosurgical Procedures/*methods
Pituitary Neoplasms/*surgery
Prolactinoma/*surgery
Dopamine Agonists/therapeutic use ; Humans ; Pituitary Neoplasms/drug therapy ; Prolactinoma/drug therapy ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Predictors of dopamine agonist resistance in prolactinoma patients.
Autorzy:: Vermeulen E; Department of Neurosurgery, VUB University Hospital of Brussels, Laarbeeklaan 101, 1090, Brussels, Belgium.
D'Haens J; Department of Neurosurgery, VUB University Hospital of Brussels, Laarbeeklaan 101, 1090, Brussels, Belgium.
Stadnik T; Department of Radiology, VUB University Hospital of Brussels, Laarbeeklaan 101, 1090, Brussels, Belgium.
Unuane D; Department of Endocrinology, VUB University Hospital of Brussels, Laarbeeklaan 101, 1090, Brussels, Belgium.
Barbe K; Department of Statistics, VUB University Hospital of Brussels, Laarbeeklaan 101, 1090, Brussels, Belgium.
Van Velthoven V; Department of Neurosurgery, VUB University Hospital of Brussels, Laarbeeklaan 101, 1090, Brussels, Belgium.
Gläsker S; Department of Neurosurgery, VUB University Hospital of Brussels, Laarbeeklaan 101, 1090, Brussels, Belgium. .; Pokaż więcej
Źródło:: BMC endocrine disorders [BMC Endocr Disord] 2020 May 19; Vol. 20 (1), pp. 68. Date of Electronic Publication: 2020 May 19.
Typ publikacji:: Journal Article
MeSH Terms:: Dopamine Agonists/*therapeutic use
Pituitary Neoplasms/*blood
Pituitary Neoplasms/*drug therapy
Prolactin/*blood
Prolactinoma/*blood
Prolactinoma/*drug therapy
Adult ; Aged ; Belgium/epidemiology ; Cabergoline/therapeutic use ; Drug Resistance/drug effects ; Drug Resistance/physiology ; Female ; Humans ; Male ; Middle Aged ; Pituitary Neoplasms/diagnostic imaging ; Predictive Value of Tests ; Prolactinoma/diagnostic imaging ; Retrospective Studies ; Tertiary Care Centers ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report.
Autorzy:: Casulari LA; Endocrinology Service of the Brasilia University Hospital, Brasilia, DF, Brazil. .; Clinic of Neurology and Endocrinology, SCN quadra 1 bloco F Ed. America Office Tower, salas 1015 e 1016, Brasilia, DF, 70711-905, Brazil. .
de Castro LF; Medical Clinic Service of the Brasilia University Hospital, Brasília, DF, Brazil.
Kessler IM; Institute of Cardiology of the Federal District, University Foundation of Cardiology, Brasília, DF, Brazil.
Mendonça JL; Clinic of Radiology Vila Rica, Brasilia, DF, Brazil.
de Fátima Magalhães Gonzaga M; Endocrinology Service of the Brasilia University Hospital, Brasilia, DF, Brazil.; Clinic of Neurology and Endocrinology, SCN quadra 1 bloco F Ed. America Office Tower, salas 1015 e 1016, Brasilia, DF, 70711-905, Brazil.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2019 Jun 16; Vol. 13 (1), pp. 183. Date of Electronic Publication: 2019 Jun 16.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Cabergoline*/administration & dosage
Cabergoline*/adverse effects
Pituitary Neoplasms*/blood
Pituitary Neoplasms*/complications
Pituitary Neoplasms*/drug therapy
Pituitary Neoplasms*/pathology
Prolactinoma*/blood
Prolactinoma*/complications
Prolactinoma*/drug therapy
Prolactinoma*/pathology
Psychotic Disorders*/diagnosis
Psychotic Disorders*/drug therapy
Psychotic Disorders*/etiology
Mirtazapine/*administration & dosage
Prolactin/*blood
Quetiapine Fumarate/*administration & dosage
Stroke/*complications
Dopamine Agonists/administration & dosage ; Dopamine Agonists/adverse effects ; Dose-Response Relationship, Drug ; Drug Therapy, Combination ; Humans ; Male ; Middle Aged ; Psychotropic Drugs/administration & dosage ; Stroke/diagnosis ; Treatment Outcome ; Tumor Burden

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Body self-image disturbances in women with prolactinoma.
Autorzy:: Pereira HS; Programa de Pós-Graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
Naliato EC; Centro de Estudos Ricardo A. T. Castilho, Associação Médica de Teresópolis, Teresópolis, RJ, Brazil.
Moraes AB; Serviço de Endocrinologia, Faculdade de Medicina, UFRJ, Rio de Janeiro, RJ, Brazil.
Gadelha MR; Serviço de Endocrinologia, Faculdade de Medicina, UFRJ, Rio de Janeiro, RJ, Brazil.
Vieira Neto L; Serviço de Endocrinologia, Faculdade de Medicina, UFRJ, Rio de Janeiro, RJ, Brazil.
Almeida RM; Instituto Alberto Luiz Coimbra de Pós-Graduação e Pesquisa de Engenharia (COPPE), UFRJ, Rio de Janeiro, RJ, Brazil.
Nardi AE; Instituto de Psiquiatria, Faculdade de Medicina, UFRJ, Rio de Janeiro, RJ, Brazil.
Violante AH; Serviço de Endocrinologia, Faculdade de Medicina, UFRJ, Rio de Janeiro, RJ, Brazil.; Pokaż więcej
Źródło:: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) [Braz J Psychiatry] 2020 Jan-Feb; Vol. 42 (1), pp. 33-39.
Typ publikacji:: Journal Article
MeSH Terms:: Body Dysmorphic Disorders/*psychology
Hyperprolactinemia/*psychology
Pituitary Neoplasms/*psychology
Prolactinoma/*psychology
Adult ; Body Image/psychology ; Body Mass Index ; Dopamine Agonists/therapeutic use ; Female ; Humans ; Hyperprolactinemia/blood ; Hyperprolactinemia/drug therapy ; Middle Aged ; Pituitary Neoplasms/blood ; Prolactin/blood ; Prolactinoma/blood ; Psychiatric Status Rating Scales ; Reference Values ; Statistics, Nonparametric ; Surveys and Questionnaires ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Alternations of Blood Pressure Following Surgical or Drug Therapy for Prolactinomas.
Autorzy:: Cheng, Yijun (AUTHOR)
Wang, Dapeng (AUTHOR)
Tang, Hao (AUTHOR)
Tong, Debing (AUTHOR)
Zhao, Weiguo (AUTHOR)
Lin, Shaojian (AUTHOR)
Yao, Hong (AUTHOR)
Lv, Wenwen (AUTHOR)
Zhang, Xun (AUTHOR)
Xue, Li (AUTHOR)
Shang, Hanbing (AUTHOR)
Wu, Zhe Bao (AUTHOR); Pokaż więcej
Źródło:: Cancers. Feb2024, Vol. 16 Issue 4, p726. 13p.

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Dopamine Agonists as a Novel "Cure" for Autoimmune Diabetes.
Autorzy:: Sahota, Shaan (AUTHOR)
Cooper, Lorcan (AUTHOR)
Sirkova, Anelia (AUTHOR)
Stojanovic, Nemanja (AUTHOR); Pokaż więcej
Źródło:: JCEM Case Reports. Feb2024, Vol. 2 Issue 2, p1-4. 4p.

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Cabergoline treatment in prolactinoma: Amelioration in obstructive and central sleep apneas.
Autorzy:: Binar M; Department of Otolaryngology, Head and Neck Surgery, Gulhane Medical School, Ankara, Turkey.
Karakoc O; Department of Otolaryngology, Head and Neck Surgery, Gulhane Medical School, Ankara, Turkey.
Haymana C; Department of Endocrinology, Gulhane Medical School, Ankara, Turkey.
Arslan H; Department of Otolaryngology, Head and Neck Surgery, Gulhane Medical School, Ankara, Turkey.; Pokaż więcej
Źródło:: Journal of postgraduate medicine [J Postgrad Med] 2019 Jan-Mar; Vol. 65 (1), pp. 47-49.
Typ publikacji:: Case Reports
MeSH Terms:: Brain/*diagnostic imaging
Cabergoline/*therapeutic use
Continuous Positive Airway Pressure/*adverse effects
Disorders of Excessive Somnolence/*etiology
Dopamine Agonists/*therapeutic use
Pituitary Neoplasms/*diagnostic imaging
Prolactinoma/*diagnostic imaging
Sleep Apnea, Obstructive/*diagnosis
Sleep Apnea, Obstructive/*therapy
Adult ; Continuous Positive Airway Pressure/methods ; Humans ; Magnetic Resonance Imaging ; Male ; Polysomnography/methods ; Sleep Apnea, Obstructive/etiology ; Snoring/etiology ; Snoring/physiopathology ; Treatment Outcome

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Giant prolactinoma, germline BRCA1 mutation, and depression: a case report.
Autorzy:: Bettencourt-Silva R; Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, E.P.E., Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal. .; Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal. .; Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal. .
Queirós J; Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, E.P.E., Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.
Pereira J; Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.; Department of Neurosurgery, Centro Hospitalar Universitário de São João, E.P.E., Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.
Carvalho D; Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, E.P.E., Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.; Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.; Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2018 Dec 06; Vol. 12 (1), pp. 360. Date of Electronic Publication: 2018 Dec 06.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: BRCA1 Protein/*genetics
Depressive Disorder/*complications
Mutation/*genetics
Pituitary Neoplasms/*complications
Prolactinoma/*complications
Adult ; Antidepressive Agents/therapeutic use ; Cabergoline/therapeutic use ; Depressive Disorder/drug therapy ; Dopamine Agonists/therapeutic use ; Female ; Humans ; Magnetic Resonance Imaging/methods ; Pituitary Neoplasms/diagnostic imaging ; Pituitary Neoplasms/therapy ; Prolactinoma/diagnostic imaging ; Prolactinoma/therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis.
Autorzy:: Hoffmann A; Department of Pediatrics and Pediatric Hematology/Oncology, Klinikum Oldenburg AöR, Medical Campus University Oldenburg, Rahel-Straus-Strasse 10, 26133, Oldenburg, Germany.
Adelmann S; Department of Pediatrics and Pediatric Hematology/Oncology, Klinikum Oldenburg AöR, Medical Campus University Oldenburg, Rahel-Straus-Strasse 10, 26133, Oldenburg, Germany.
Lohle K; Department of Pediatrics and Pediatric Hematology/Oncology, Klinikum Oldenburg AöR, Medical Campus University Oldenburg, Rahel-Straus-Strasse 10, 26133, Oldenburg, Germany.
Claviez A; Department of Pediatric Oncology, University Hospital, Kiel, Germany.
Müller HL; Department of Pediatrics and Pediatric Hematology/Oncology, Klinikum Oldenburg AöR, Medical Campus University Oldenburg, Rahel-Straus-Strasse 10, 26133, Oldenburg, Germany. .; Pokaż więcej
Źródło:: European journal of pediatrics [Eur J Pediatr] 2018 Jan; Vol. 177 (1), pp. 125-132. Date of Electronic Publication: 2017 Nov 22.
Typ publikacji:: Journal Article
MeSH Terms:: Pituitary Neoplasms*/diagnosis
Pituitary Neoplasms*/mortality
Pituitary Neoplasms*/therapy
Prolactinoma*/diagnosis
Prolactinoma*/mortality
Prolactinoma*/therapy
Adolescent ; Child ; Decompression, Surgical ; Dopamine Agonists/therapeutic use ; Female ; Follow-Up Studies ; Humans ; Male ; Prognosis ; Retrospective Studies ; Survival Analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Sjögren's Syndrome Accompanied by Prolactinoma: a case report and literature review.
Autorzy:: Oh YJ; Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School of Chonbuk National Unversity, Jeonju, Korea.
Lee WS; Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School of Chonbuk National Unversity, Jeonju, Korea.
Yoo WH; Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School of Chonbuk National Unversity, Jeonju, Korea.
Hahm JR; Divison of Endocrinology, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.
Kim HO; Divison of Rheumatology, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.
Suh YS; Divison of Rheumatology, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.
Lee SI; Divison of Rheumatology, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.
Cheon YH; Divison of Rheumatology, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.; Pokaż więcej
Źródło:: International journal of rheumatic diseases [Int J Rheum Dis] 2017 Nov; Vol. 20 (11), pp. 1823-1826. Date of Electronic Publication: 2015 Sep 10.
Typ publikacji:: Case Reports; Letter
MeSH Terms:: Pituitary Neoplasms/*etiology
Prolactinoma/*etiology
Sjogren's Syndrome/*complications
Antineoplastic Agents, Hormonal/therapeutic use ; Biomarkers, Tumor/blood ; Bromocriptine/therapeutic use ; Dopamine Agonists/therapeutic use ; Female ; Humans ; Magnetic Resonance Imaging ; Pituitary Neoplasms/blood ; Pituitary Neoplasms/diagnostic imaging ; Pituitary Neoplasms/drug therapy ; Prolactin/blood ; Prolactinoma/blood ; Prolactinoma/diagnostic imaging ; Prolactinoma/drug therapy ; Sjogren's Syndrome/blood ; Sjogren's Syndrome/diagnosis ; Sjogren's Syndrome/drug therapy ; Treatment Outcome ; Young Adult

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells.
Autorzy:: Huang J; Department of Neurosurgery, Shanghai Institute of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Zhang F; Department of Neurosurgery, The 411th Hospital of PLA, Shanghai, China.
Jiang L; Department of Neurosurgery, Shanghai Institute of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Hu G; Department of Neurosurgery, Shanghai Institute of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Sun W; Department of Neurosurgery, Shanghai Institute of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Zhang C; Department of Neurosurgery, Shanghai Institute of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Ding X; Department of Neurosurgery, Shanghai Institute of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.; Pokaż więcej
Źródło:: Cancer research and treatment [Cancer Res Treat] 2017 Apr; Vol. 49 (2), pp. 358-373. Date of Electronic Publication: 2016 Jul 28.
Typ publikacji:: Journal Article
MeSH Terms:: Apoptosis/*drug effects
Apoptosis/*genetics
Bromocriptine/*pharmacology
Dopamine Agonists/*pharmacology
Pituitary Neoplasms/*genetics
Prolactinoma/*genetics
S-Phase Kinase-Associated Proteins/*genetics
Adult ; Aged ; Aged, 80 and over ; Cell Line, Tumor ; Female ; Gene Expression ; Gene Knockdown Techniques ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Pituitary Neoplasms/diagnosis ; Pituitary Neoplasms/metabolism ; Prolactin/metabolism ; Prolactinoma/diagnosis ; Prolactinoma/metabolism ; Proteolysis ; S-Phase Kinase-Associated Proteins/antagonists & inhibitors ; S-Phase Kinase-Associated Proteins/metabolism ; Tumor Burden ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism ; Ubiquitination

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Pregnancy and tumor outcomes in infertile women with macroprolactinoma on cabergoline therapy.
Autorzy:: Rastogi A; a Department of Endocrinology , Post Graduate Institute of Medical education and Research (PGIMER) , Chandigarh, 160012 , India.
Bhadada SK; a Department of Endocrinology , Post Graduate Institute of Medical education and Research (PGIMER) , Chandigarh, 160012 , India.
Bhansali A; a Department of Endocrinology , Post Graduate Institute of Medical education and Research (PGIMER) , Chandigarh, 160012 , India.; Pokaż więcej
Źródło:: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology [Gynecol Endocrinol] 2017 Apr; Vol. 33 (4), pp. 270-273. Date of Electronic Publication: 2016 Dec 02.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents/*therapeutic use
Dopamine Agonists/*therapeutic use
Ergolines/*therapeutic use
Infertility, Female/*drug therapy
Pituitary Neoplasms/*drug therapy
Pregnancy Complications, Neoplastic/*drug therapy
Prolactinoma/*drug therapy
Adult ; Cabergoline ; Female ; Humans ; Pregnancy ; Pregnancy Outcome ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Dopamine -- Agonists"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język